MedTrace Logo

Airway Responses to Montelukast and Desloratadine.

NCT00424580 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2008-01-23

No results posted yet for this study

Summary

Montelukast (for asthma) and desloratadine (for allergies) are effective therapy for their current uses. Part of what happens when your allergies trigger your asthma should be prevented by either of these drugs. This project is being conducted to determine if these drugs are effective, either alone or in combination, on controlling asthma that is triggered by allergies.

Conditions

Interventions

DRUG

Montelukast (10mg) and Desloratadine (5mg)

Sponsors & Collaborators

  • University of Saskatchewan

    lead OTHER

Principal Investigators

  • Donald W Cockcroft, MD, FRCP(C) · University of Saskatchew Full Professor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2007-08-31
Completion
2007-08-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00424580 on ClinicalTrials.gov